Navigation Links
Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
Date:1/7/2008

CHESHIRE, Conn., Jan. 7 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. (the "Company," Nasdaq: ALXN) today announced that it has commenced dosing in the AEGIS study, a single registration study to evaluate the safety, efficacy, and pharmacology of Soliris(R) (eculizumab) as a treatment for Japanese patients with paroxysmal nocturnal hemoglobinuria (PNH). When fully enrolled, the open-label study, authorized by Japan's Pharmaceutical and Medical Device Administration (PMDA), is expected to include approximately 25 patients with PNH at clinical sites throughout Japan. Each PNH patient in the AEGIS study will be dosed with Soliris for 12 weeks after enrollment.

PNH is a rare acquired genetic blood disorder defined by hemolysis, in which patients' red blood cells are destroyed by complement, a component of the body's immune system. The primary efficacy endpoint of the study is reduction of hemolysis from baseline. The study will also measure the effect of Soliris on other clinical manifestations of PNH, including blood transfusion requirements, thromboses (blood clots), and kidney function. Patients' overall quality of life, including fatigue, will also be assessed.

The inclusion and exclusion criteria for the AEGIS study are similar to those used in one of Alexion's previous Phase 3 studies of Soliris as a treatment for PNH, the SHEPHERD study. SHEPHERD examined the safety and efficacy of eculizumab in a broad and diverse population of patients with PNH, including enrollment of patients with minimal transfusion requirements and/or evidence of thrombocytopenia. (1) Based on the SHEPHERD study and the TRIUMPH Phase 3 study, (2) Soliris was approved as the first treatment for patients with PNH by the U.S. Food and Drug Administration in March 2007 and by the European Commission in June 2007.

"Commencing patient dosing with eculizumab in the Japanese registration study represents an important step toward providing patients with PNH in J
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
2. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
3. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
4. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
5. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
6. Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
7. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
8. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
9. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
10. MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule
11. VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... Research and Markets ... of the "North American Computerized Physician ... Physician Order Entry, Standalone Computerized Physician Order ... Forecast to 2019 " report to ... , The North American computerized ...
(Date:5/26/2015)... May 26, 2015  EndoChoice today announced the launch ... its common stock, which will represent 25.6% of its ... Delaware corporation in connection with the ... to be between $15 and $17 per share. The ... option to purchase up to an additional 937,500 shares ...
(Date:5/26/2015)... May 26, 2015  Advanzeon Solutions, Inc. (OTC:BB: ... Management Solutions, Inc. ("PVMS"), (sometimes, collectively referred to ... Mr. Matt Capps has joined the ... to the Company,s Community Outreach Programs.  Mr. Capps ... This engagement provides for Mr. Capps to form ...
Breaking Medicine Technology:North American Computerized Physician Order Entry Market 2015-2019 2EndoChoice Announces Launch of Its Initial Public Offering 2Advanzeon Solutions, Inc. And Its Wholly-Owned Subsidiary, Pharmacy Value Management Solutions, Inc., Welcome Major League Baseball Great Matt Capps As Senior Public Relations Consultant 2Advanzeon Solutions, Inc. And Its Wholly-Owned Subsidiary, Pharmacy Value Management Solutions, Inc., Welcome Major League Baseball Great Matt Capps As Senior Public Relations Consultant 3Advanzeon Solutions, Inc. And Its Wholly-Owned Subsidiary, Pharmacy Value Management Solutions, Inc., Welcome Major League Baseball Great Matt Capps As Senior Public Relations Consultant 4
... June 22 The SCOOTER Store today announced a major milestone, ... delivery of a power wheelchair to Earvin Thompson of ... from the nation,s leading provider of power mobility equipment, will enjoy more ... , , ...
... GRONINGEN, The Netherlands , ... the Netherlands , announced this week that in ... it has obtained outstanding,results for the treatment of inhalation ... be achieved with extended time to treatment (48h post,infection) ...
Cached Medicine Technology:The SCOOTER Store Marks Half-Millionth Life Changed 2The SCOOTER Store Marks Half-Millionth Life Changed 3The SCOOTER Store Marks Half-Millionth Life Changed 4Survival Rate Up to 100% for Late Stage Treatment of Anthrax Infections 2
(Date:5/26/2015)... Pasadena porcelain veneers dentist, Dr. ... cosmetic treatments. Cosmetic dentistry is becoming increasingly popular in ... are committed to providing you with the highest level ... and a smile of a lifetime … We work ... to change your life,” explains Dr. Martirosyan’s team. “Giving ...
(Date:5/26/2015)... May 26, 2015 Indosoft, Inc ... upgrade of the DMi Partners contact center ... the first in Indosoft's contact center ACD system to ... screen support for such trunk features as diversion headers, ... management, and included upgrades to warm transfers ...
(Date:5/26/2015)... May 26, 2015 National Prevention Week ... year. It is supported by the Substance Abuse ... raising public awareness of, and action about, substance abuse ... organizations and coalitions are encouraged to join in promoting ... and related issues, and in building community partnerships. , ...
(Date:5/26/2015)... i2i Systems, the leader in integrated Population ... years, has earned 2014 Patient Centered Medical Home prevalidation ... for its flagship product i2iTracks , the company ... we have done to create healthier populations for so ... NCQA once again,” said Janice Nicholson, co-founder and CEO ...
(Date:5/26/2015)... Award-winning travel photographer and life coach Raul Espinoza creates ... connect viewers to the beauty of the world while making ... Raul has traveled the world documenting lives, and then shared ... bounded by our circumstances. , “KAWSAY” means “life” ... The photo gallery show by the same name will support ...
Breaking Medicine News(10 mins):Health News:Pasadena Porcelain Veneers Expert, Marine Martirosyan DDS, is Now Offering Complimentary Dental Cleaning with Cosmetic Treatments 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 3Health News:Narconon Arrowhead Takes Part in National Prevention Week 2Health News:Narconon Arrowhead Takes Part in National Prevention Week 3Health News:i2iTracks Earns NCQA 2014 PCMH Prevalidation 2Health News:i2iTracks Earns NCQA 2014 PCMH Prevalidation 3Health News:A Photographer & Two Educational Organiazations Join to Make a Difference in Our Youth 2
... Life Sciences has submitted an application with the Drug ... phase-1 clinical trials of its new drug Suvn-502 for ... ,'Treatment for Alzheimer's disease and Schizophrenia is ... to discover drugs that address significant unmet medical needs,' ...
... Nepalese doctors has developed a drug that is more ... reported Friday . ,The drug also costs ... Organization (WHO), reported The Himalayan Times daily.Doctors at the ... typhoid patients. ,,The team compared the effectiveness ...
... 1,763 food shipments from India, 1,480 from Mexico and 1,368 ... year . ,Some of India's spices, seeds and ... found too filthy to eat. Chinese products like seafood, bean ... has reported. ,,But the FDA did not reveal the ...
... for the high-tech dental lasers used mainly to prepare cavities ... conducted by researchers in Austria, these advanced dental lasers can ... study credits the progress of miniaturized, flexible fiber tips for ... treatment. ,Dr. Ulrich Schoop and a team of ...
... on the Yamuna River that flows past India's capital, it's easy ... surface by rotting sewage -- and that's after at least ... ,Now, with New Delhi to host the Commonwealth Games in ... built on the stinking river's banks, India must do in three ...
... the end of the last century death rates from breast ... Long waiting lists, resulting in delayed diagnosis and treatment, were ... is failing breast cancer patients and needs to be reviewed ... brought in the 2 week wait rule which stipulated that ...
Cached Medicine News:Health News:US Rejects More Food from India Than from Any Other Country 2Health News:Millions Spent, but the Indian Capital's River Still Stinks 2Health News:Millions Spent, but the Indian Capital's River Still Stinks 3Health News:Two Week Wait Rule Not Working With Breast Cancer Patients 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: